Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03339232 · ClinicalTrials.gov registry record · NA
BCAA Supplemental Study
A NA study, sponsored by Loyola University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03339232: Completed NA study, sponsored by Loyola University.
NCT03339232 is a NA study that has completed, run by Loyola University. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03339232, a NA study, has completed, sponsored by Loyola University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The central hypothesis of this study is that BCAA supplementation and BCAA supplementation plus low-intensity activity will improve muscle mass and HRQOL in cirrhotic patients compared to usual care
Primary Outcome
Appendicular lean muscle mass will be measured by whole body DXA using a standard protocol.
Interventions
- OTHER Physical Activity
- DIETARY_SUPPLEMENT BCAA Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2017-10-02 |
| Est. Completion | 2019-06-17 |
| Phase | NA |
What the finished NCT03339232 record still lists
NCT03339232 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Physical Activity is the first listed.
NCT03339232 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03339232 about?
NCT03339232 is a clinical study titled "BCAA Supplemental Study". The central hypothesis of this study is that BCAA supplementation and BCAA supplementation plus low-intensity activity will improve muscle mass and HRQOL in cirrhotic patients compared to usual care
What is the current status of trial NCT03339232?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2017-10-02. Estimated completion is 2019-06-17.
What interventions are being tested in trial NCT03339232?
The interventions under investigation include: Physical Activity (OTHER), BCAA Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03339232?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03339232's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI